Cavanaugh Group, Inc.’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cavanaugh Group, Inc.'s GILD Position: Q3 2026 in Review
Cavanaugh Group, Inc. opened a new position in Gilead Sciences (GILD) in Q3 2026: 14 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #140 among its holdings.
2,341 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Cavanaugh Group, Inc. held 14 shares of Gilead Sciences worth $2.42K as of Q3 2026.
- Gilead Sciences was a new Cavanaugh Group, Inc. position in Q3 2026.
- Gilead Sciences made up ﹤0.01% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #140 holding.
- 2,341 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.